EC Number   |
|---|
   3.4.22.62 | - |
| 3.4.22.62 | adenovirus expression, AdshRNA-C9 and AdshRNA-eGFP vectors, AdBcl-xL and AdNull adenoviral vectors |
| 3.4.22.62 | B6 splenocytes modified by retroviral transduction, truncated caspase-9 molecule genetically coupled to a modified human FK506-binding protein (FKBPF36V) by generating the iCasp9M-construct, iCasp9M construct (safety switch) and enhanced GFP used for transformation |
| 3.4.22.62 | caspase-9 inactivated by mutation at the catalytic domain, generation of dominant negative caspase-9 overexpressing cell lines, expression in Escherichia coli, follicular lymphoma cells transformed with the lentiviral vector pWPI-IRES-GFP |
| 3.4.22.62 | caspase-9 splice variant Casp9-gamma contains only a caspase recruitment domain and lacks the catalytic domain, expression in 293T cells.Casp9-gamma does not promote apoptosis when overexpressed in 293T cells |
| 3.4.22.62 | caspase-9S is cloned from human liver cDNA |
| 3.4.22.62 | expressed in Escherichia coli |
| 3.4.22.62 | expressed in Escherichia coli, pcmyc vector, pFLAG-CTC vector to generate FLAG-tagged caspase-9 construct |
| 3.4.22.62 | expressed in Escherichia coli, recombinant protein, pcDNA3, pET28a, pEGFP vectors |
| 3.4.22.62 | expression in Escherichia coli |
